Hardware · Updated 14 Oct, 04:43 am IST
Science Corporation implants PRIMA chip in first Stargardt disease patient
Why it matters for readers: Helps you understand that some devices can partially restore vision by replacing damaged parts of the retina.
- Science Corporation has implanted its PRIMA retinal prosthesis into a first patient with Stargardt disease, the company announced.1
- CEO Max Hodak announced the implantation on stage at TechCrunch Disrupt and described retinal prostheses as a type of brain‑computer interface.1
- PRIMA is commercially available in Europe for geographic atrophy and the company believes the approach can apply to multiple diseases including Stargardt disease.1
- Stargardt disease causes progressive loss of central vision by damaging the outer retina while often sparing the inner retina that sends signals to the brain.1
- About 150,000 people worldwide have lost vision due to Stargardt disease, according to the announcement.1
Get a brief like this every morning
Uzha reads hundreds of sources and gives you the stories that matter for your work, with every source linked. Free.
Get started